Louise Mountford, a farm operator in Shropshire,spent four years battling mysterious digestive and dryness issues before receiving a diagnosis of Sjögren's disease. After multiple negative tests and emergency hospital visits, blood work finally revealed the autoimmune condition affecting her secretory glands.

The four-year gap between Louise Mountford's first symptoms and her diagnosis

For more than four years, Louise Mountford experienced a debilitating array of symptoms that defied standard medical screening. According to the report, these included explosive diarrhoea, painful bloating, and a sudden inability to swallow dry food, which began in her late 50s. The severity of her condition peaked during one incident where she was rushed to the hospital via ambulance in agonizing pain, yet doctors initially dismissed the episode as probable constipation , treaating her with an enema and paracetamol.

Despite undergoing both a gastroscopy and a colonoscopy, medical professionals found no obious cause for her distress. The frustration for Louise Mountford was compounded by the emergence of seemingly unrelated issues, such as jaw pain, dental problems, and a total lack of tears that left her unable to cry. This fragmented symptom profile often leads to a diagnostic stalemate where patients are treated for isolated issues rather than a systemic cause.

How anti-Ro/SSA and anti-La antibodies solved a medical mystery

The breakthrough for Louise Mountford came only after she sought help from a private gastroenterologist. While a gut transit test involving a camera-equipped pill failed to find physical abnormalities,specific blood tests identified the presence of anti-Ro/SSA and anti-La antibodies. As the report says, these specific markers are closely associated with Sjögren's disease, an autoimmune condition where the body's immune system attacks tissues responsible for producing moisture.

Once these antibodies were identified, a private consultation with a rheumatologist confirmed the diagnosis. This discovery linked her digestive turmoil to the same systemic failure causing her dry mouth and eyes . It highlights a critical diagnostic path: when imaging and endoscopic tests fail , serological markers for autoimmune activity may be the only way to identify the root cause of systemic dryness.

The 95 per cent gut-symptom rate found by Limoges University Hospital

While Sjögren's is often characterized primarily by dry eyes and mouth, its impact on the gastrointestinal tract is far more prevalent than commonly understood. Professor Simon Bowman of the University Hospitals Birmingham NHS Trust explains that the disease affects secretory glands throughout the entire body, spanning from the mouth to the anus, including the lungs and bowel. This systemic reach explains why patients like Louise Mountford experience such severe abdominal distress.

The connection between the immune system and the gut is backed by clinical data. Research from Limoges University Hospital in France, published in 2021 in Advances in Rheumatology, found that 95 per cent of the Sjögren's patients studied suffered from gut symptoms, specifically abdominal pain and constipation. This suggests that gastrointestinal distress should be viewed as a primary indicator rather than a secondary complication of the disease.

Why 1 per cent of the population may be overlooking Sjögren's

The prevalence of Sjögren's disease is currently underestimated due to a lack of clinical awareness and the varied nature of its presentation . Dr. Kelsey Jordan of the University Hospitals Sussex NHS Foundation Trust notes that while the condition is believed to affect roughly 1 per cent of the population,some estimates suggest as many as half a million people may be suffering. the disease typically targets women between the ages of 40 and 60, though 10 per cent of cases occur in men.

Despite these numbers, significant gaps in medical knowledge remain. While Dr. Jordan mentions that certain genes are implicated in the cause of Sjögren's, the specific genetic markers remain unnamed in current general reporting. Furthermore, it remains unclear why some patients present with mild dryness while others, like Louise Mountford, experience acute, emergency-level abdominal pain. This inconsistency means many patients may never be referred to a specialist, missing out on essential treatment for years.